Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 200 Total
GTI - Graphjet Technology - Stock Price Chart
TickerGTI [NASD]
CompanyGraphjet Technology
IndustryOther Industrial Metals & Mining
Market Cap1.09BEPS (ttm)0.07
P/E103.57EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.60EPS Q/Q50.33%
Dividend-Sales Q/Q-
Insider Own40.25%Inst Own0.30%
Insider Trans0.00%Inst Trans-0.18%
Short Float0.03%Earnings-
Analyst Recom-Target Price-
Avg Volume68.01K52W Range3.40 - 14.00
Graphjet Technology engages in the manufacture of artificial graphene and graphite, a critical raw material used in a variety of industries, such as biomedical, automobile composition and coating, electronics and home appliances, food and beverage processing, energy storage, batteries in electric vehicles, mechanical strength enhancement, sensors, semiconductors, and digital products. The company is headquartered in Kuala Lumpur, Malaysia.
FTEL - Fitell Corp - Stock Price Chart
CompanyFitell Corp
IndustrySpecialty Retail
Market Cap99.64MEPS (ttm)-0.38
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S25.75EPS next 5Y-
P/B10.00EPS Q/Q-4416.98%
Dividend-Sales Q/Q-30.48%
Insider Own57.91%Inst Own0.10%
Insider Trans0.00%Inst Trans-
Short Float1.73%Earnings-
Analyst Recom-Target Price-
Avg Volume421.52K52W Range0.88 - 9.20
Fitell Corp. is an online retailer of gym and fitness equipment. Its brands include Muscle Motion, Rapid Motion, and FleetX. The company was founded in 2007 and is headquartered in Sydney, Australia.
REBN - Reborn Coffee Inc - Stock Price Chart
CompanyReborn Coffee Inc
Market Cap4.13MEPS (ttm)-2.40
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-267.17%
P/S0.69EPS next 5Y-
P/B1.80EPS Q/Q22.85%
Dividend-Sales Q/Q108.97%
Insider Own68.41%Inst Own0.13%
Insider Trans0.00%Inst Trans-
Short Float8.27%EarningsMar 28/b
Analyst Recom1.00Target Price16.00
Avg Volume137.65K52W Range0.92 - 8.80
Reborn Coffee, Inc. engages in the franchise of retail locations and kiosks of coffee, water, and other beverages. The company was founded by Jay Kim on July 31, 2015 and is headquartered in Brea, CA.
ANL - Adlai Nortye Ltd. ADR - Stock Price Chart
TickerANL [NASD]
CompanyAdlai Nortye Ltd. ADR
Market Cap1.35BEPS (ttm)-
P/E-EPS this Y15.17%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-90.91%
P/S-EPS next 5Y-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.07%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom1.00Target Price30.00
Avg Volume7.39K52W Range7.11 - 19.30
Adlai Nortye Ltd. operates as a clinical-stage biopharmaceutical company focused on the development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018 and is headquartered in Hangzhou, China.
RCAT - Red Cat Holdings Inc - Stock Price Chart
CompanyRed Cat Holdings Inc
IndustryComputer Hardware
Market Cap96.56MEPS (ttm)-0.51
P/E-EPS this Y44.00%
Forward P/E-EPS next Y57.14%
PEG-EPS past 5Y-
P/S7.03EPS next 5Y-
P/B1.95EPS Q/Q5.56%
Dividend-Sales Q/Q88.24%
Insider Own30.12%Inst Own20.53%
Insider Trans0.00%Inst Trans3.30%
Short Float0.80%EarningsMar 18/a
Analyst Recom1.00Target Price5.00
Avg Volume385.93K52W Range0.52 - 1.50
Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the following segments: Enterprise and Consumer segments. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Evans Allan ThomasCOO, Red Cat Holdings, Inc.Sep 27 '23Buy0.9610,0009,6501,443,945Sep 27 04:01 PM
ELTX - Elicio Therapeutics Inc. - Stock Price Chart
CompanyElicio Therapeutics Inc.
Market Cap99.74MEPS (ttm)-6.15
P/E-EPS this Y45.69%
Forward P/E-EPS next Y-10.85%
PEG-EPS past 5Y3.87%
P/S-EPS next 5Y-
P/B8.22EPS Q/Q56.43%
Dividend-Sales Q/Q-
Insider Own28.52%Inst Own3.46%
Insider Trans71.04%Inst Trans-2.78%
Short Float0.54%EarningsMar 29/b
Analyst Recom2.00Target Price11.00
Avg Volume64.25K52W Range2.96 - 24.39
Apr-05-24 04:30PM Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting (GlobeNewswire) +17.69%
Apr-02-24 07:53AM ELTX Stock Earnings: Elicio Therapeutics Misses EPS for Q4 2023 (InvestorPlace)
Mar-29-24 08:30AM Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
Mar-18-24 08:00AM Elicio Therapeutics Announces $6.0 Million Private Placement Financing (GlobeNewswire) +28.00%
Mar-06-24 08:30AM Elicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Feb-05-24 08:30AM Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-25-24 09:00AM Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors (GlobeNewswire) +16.67%
Jan-17-24 08:30AM Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium (GlobeNewswire)
Jan-16-24 08:30AM Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference (GlobeNewswire)
Jan-11-24 08:30AM Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study (GlobeNewswire)
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chudnovsky YekaterinaDirectorDec 22 '23Buy5.811,213,0007,047,5301,915,639Dec 26 04:29 PM
GREE - Greenidge Generation Holdings Inc - Stock Price Chart
CompanyGreenidge Generation Holdings Inc
IndustryCapital Markets
Market Cap28.29MEPS (ttm)-3.32
P/E-EPS this Y72.06%
Forward P/E-EPS next Y-43.16%
PEG-EPS past 5Y36.24%
P/S0.40EPS next 5Y-
P/B-EPS Q/Q101.07%
Dividend-Sales Q/Q22.67%
Insider Own33.26%Inst Own6.53%
Insider Trans0.18%Inst Trans7.88%
Short Float5.82%EarningsApr 10/b
Analyst Recom1.00Target Price6.00
Avg Volume295.96K52W Range1.55 - 9.26
Greenidge Generation Holdings, Inc. owns and operates a vertically integrated Bitcoin mining and power generation facility. It engages in the mining of Bitcoin and contributes to the security and transactability of the Bitcoin ecosystem while concurrently meeting the power needs of homes and businesses. The company was founded in 2014 and is headquartered Fairfield, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Irwin DalePresidentFeb 28 '24Sale4.185,64623,600104,739Mar 01 02:36 PM
Kovler JordanChief Executive OfficerFeb 20 '24Buy3.872,0007,74012,000Feb 21 02:46 PM
Kovler JordanChief Executive OfficerFeb 16 '24Buy4.071,5006,11210,000Feb 21 02:46 PM
Kovler JordanChief Executive OfficerFeb 05 '24Buy3.293,05010,0248,500Feb 07 11:18 AM
Kovler JordanChief Executive OfficerNov 16 '23Buy5.215,00026,0505,450Nov 20 05:15 PM
TARA - Protara Therapeutics Inc - Stock Price Chart
CompanyProtara Therapeutics Inc
Market Cap34.86MEPS (ttm)-3.57
P/E-EPS this Y-1.85%
Forward P/E-EPS next Y-13.59%
PEG-EPS past 5Y39.98%
P/S-EPS next 5Y-
P/B0.51EPS Q/Q73.99%
Dividend-Sales Q/Q-
Insider Own19.88%Inst Own41.89%
Insider Trans0.00%Inst Trans-4.11%
Short Float0.71%EarningsMar 13/b
Analyst Recom1.00Target Price27.80
Avg Volume236.74K52W Range1.04 - 5.24
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.
SUGP - SU Group Holdings Ltd. - Stock Price Chart
CompanySU Group Holdings Ltd.
CountryHong Kong
IndustrySecurity & Protection Services
Market Cap29.68MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
Dividend-Sales Q/Q-
Insider Own72.91%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float1.06%Earnings-
Analyst Recom-Target Price-
Avg Volume398.58K52W Range1.83 - 5.86
SU Group Holdings Ltd. engages in the provision of integrated security-related services. Its services include threat detection, traffic and vehicle control, pedestrian access control, ELV system, security personnel, and vocational training. It operates through the Security-related Engineering Services, and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.
CARM - Carisma Therapeutics Inc - Stock Price Chart
CompanyCarisma Therapeutics Inc
Market Cap77.68MEPS (ttm)-3.47
P/E-EPS this Y50.24%
Forward P/E-EPS next Y-0.19%
PEG-EPS past 5Y24.98%
P/S5.21EPS next 5Y-
P/B2.86EPS Q/Q30.54%
Dividend-Sales Q/Q-
Insider Own53.42%Inst Own17.78%
Insider Trans0.00%Inst Trans-32.33%
Short Float8.17%EarningsApr 01/b
Analyst Recom1.40Target Price9.40
Avg Volume166.23K52W Range1.53 - 9.77
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in 2016 and is headquartered in Philadelphia, PA.